The Effect Of Methotrexate On Adalimumab Pharmacokinetics: Pooled Analysis Of Adalimumab Pharmacokinetics In Patients With Rheumatoid Arthritis After Subcutaneous Administration.

被引：0
|
作者：
Awni, Walid [1 ]
Pilari, Sabine [2 ]
Ahmed, Ghada [1 ]
Noertersheuser, Peter [2 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
[2] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
488
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [21] PHARMACOKINETICS AND PHARMACODYNAMICS OF METHOTREXATE POLYGLUTAMATE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH LOW OR HIGH DOSE-METHOTREXATE IN COMBINATION WITH ADALIMUMAB: RESULTS FROM THE MIRACLE TRIAL
    Tamai, H.
    Ikeda, K.
    Miyamoto, T.
    Taguchi, H.
    Kuo, C. F.
    Shin, K.
    Hirata, S.
    Okano, Y.
    Sato, S.
    Yasuoka, H.
    Choi, I. A.
    Park, S. H.
    Weng, M. Y.
    Kuwana, M.
    Lee, Y. J.
    Ishii, T.
    Kim, J.
    Kameda, H.
    Kojima, T.
    Baek, H. J.
    Hsu, P. N.
    Huang, C. M.
    Cheng, T. T.
    Sung, W. Y.
    Tsai, W. C.
    Taninaga, T.
    Mori, M.
    Miyagishi, H.
    Sato, Y.
    Takeuchi, T.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 84 - 85
  • [22] A subcutaneous administration regimen for abatacept in patients with rheumatoid arthritis: Pharmacokinetics, safety and immunogenicity
    Corbo, M.
    Valencia, X.
    Raymond, R.
    Summerill, R.
    Agrawal, S.
    Shergy, W.
    Tay, L.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S307 - S307
  • [23] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Stephanie F. Ling
    Nisha Nair
    Suzanne M. M. Verstappen
    Anne Barton
    Hans-Dieter Zucht
    Petra Budde
    Peter Schulz-Knappe
    Darren Plant
    The Pharmacogenomics Journal, 2020, 20 : 516 - 523
  • [24] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Ling, Stephanie F.
    Nair, Nisha
    Verstappen, Suzanne M. M.
    Barton, Anne
    Zucht, Hans-Dieter
    Budde, Petra
    Schulz-Knappe, Peter
    Plant, Darren
    PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 516 - 523
  • [25] Pharmacokinetics of etanercept after once weekly subcutaneous administration of 50 mg doses to rheumatoid arthritis patients
    Nestorov, I
    Lebsack, M
    DeVries, T
    Burge, DJ
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 182 - 182
  • [26] Total and free methotrexate pharmacokinetics in rheumatoid arthritis patients
    Edno, L
    Bressolle, F
    Gomeni, R
    Bologna, C
    Sany, J
    Combe, B
    THERAPEUTIC DRUG MONITORING, 1996, 18 (02) : 128 - 134
  • [27] The effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
    Atzeni, F
    Minonzio, F
    Sarzi-Puttini, P
    Bonara, P
    Carrabba, M
    Capsoni, F
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S87 - S88
  • [28] Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
    Franco Capsoni
    Piercarlo Sarzi-Puttini
    Fabiola Atzeni
    Francesca Minonzio
    Paola Bonara
    Andrea Doria
    Mario Carrabba
    Arthritis Res Ther, 7
  • [29] Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
    Capsoni, F
    Sarzi-Puttini, P
    Atzeni, F
    Minonzio, F
    Bonara, P
    Doria, A
    Carrabba, M
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (02) : R250 - R255
  • [30] Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
    Keystone, Edward C.
    Breedveld, Ferdinand C.
    Kupper, Hartmut
    Li, Yihan
    Florentinus, Stefan
    Sainsbury, Iain
    RMD OPEN, 2018, 4 (01):
12345